HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Russell G Foster Selected Research

melanopsin

1/2015Using siRNA to define functional interactions between melanopsin and multiple G Protein partners.
6/2014Impact of cataract surgery on sleep in patients receiving either ultraviolet-blocking or blue-filtering intraocular lens implants.
1/2013The circadian control of sleep.
1/2012Profound defects in pupillary responses to light in TRPM-channel null mice: a role for TRPM channels in non-image-forming photoreception.
4/20072-Aminoethoxydiphenylborane is an acute inhibitor of directly photosensitive retinal ganglion cell activity in vitro and in vivo.
1/2006Light-evoked FOS induction within the suprachiasmatic nuclei (SCN) of melanopsin knockout (Opn4-/-) mice: a developmental study.
1/2005Melanopsin (Opn4) positive cells in the cat retina are randomly distributed across the ganglion cell layer.
8/2003VA opsin, melanopsin, and an inherent light response within retinal interneurons.
5/2003Melanopsin retinal ganglion cells and the maintenance of circadian and pupillary responses to light in aged rodless/coneless (rd/rd cl) mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Russell G Foster Research Topics

Disease

11Ganglion Cysts (Ganglion)
01/2015 - 01/2003
6Schizophrenia (Dementia Praecox)
11/2021 - 01/2006
2Sleep Initiation and Maintenance Disorders (Insomnia)
10/2017 - 05/2015
2Paranoid Disorders (Paranoia)
10/2017 - 05/2015
2Cataract (Cataracts)
06/2014 - 07/2009
2Retinitis Pigmentosa (Pigmentary Retinopathy)
11/2012 - 01/2003
2Retinal Degeneration
02/2012 - 06/2004
2Photophobia (Light Sensitivity)
08/2003 - 08/2003
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
10/2021
1Wasting Syndrome (Wasting Disease)
10/2021
1Chronobiology Disorders (Circadian Rhythm Disorder)
10/2021
1Bipolar Disorder (Manic Depressive Psychosis)
01/2021
1Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome)
05/2019
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2019
1Hallucinations (Hallucination)
10/2017
1Sleepiness
08/2016
1Sleep Deprivation
01/2015
1Vision Disorders (Hemeralopia)
06/2014
1Mental Disorders (Mental Disorder)
01/2013
1Macular Degeneration (Age-Related Maculopathy)
07/2009

Drug/Important Bio-Agent (IBA)

9melanopsinIBA
01/2015 - 05/2003
6MelatoninIBA
05/2019 - 02/2004
4Retinaldehyde (Retinal)IBA
01/2019 - 01/2005
2AcidsIBA
11/2021 - 01/2018
2AMPA Receptors (AMPA Receptor)IBA
11/2021 - 01/2018
2Glutamic Acid (Glutamate)FDA Link
11/2021 - 01/2015
2Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2015
2Dihydrotachysterol (AT 10)IBA
10/2017 - 05/2015
2OpsinsIBA
08/2003 - 01/2003
1DystrophinIBA
10/2021
1LithiumIBA
01/2021
1Capsules (Microcapsules)IBA
08/2016
1CryptochromesIBA
01/2015
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2015
1Neuregulin-1 (Neuregulin 1)IBA
01/2015
1Type II Vasoactive Intestinal Peptide ReceptorsIBA
01/2015
1Biological ProductsIBA
01/2013
1Rhodopsin (Visual Purple)IBA
11/2012
1Protein Isoforms (Isoforms)IBA
09/2009
1Ion Channels (Ion Channel)IBA
04/2007
1TRPC6 Cation ChannelIBA
04/2007
1Complementary DNA (cDNA)IBA
06/2004
1Hormones (Hormone)IBA
02/2004
1Fura-2 (Fura 2)IBA
08/2003
1Epidermal Growth Factor (EGF)IBA
01/2003
1ribosomal protein 29 (RP29)IBA
01/2003

Therapy/Procedure

2Therapeutics
10/2017 - 05/2015
2Intraocular Lenses (Intraocular Lens)
06/2014 - 07/2009
1Drug Therapy (Chemotherapy)
01/2021